The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Antithrombin Market Research Report 2025
Synopsis
Antithrombin is a protein in the blood that plays a crucial role in regulating blood clotting. It is a natural anticoagulant that inhibits or blocks the activity of certain clotting factors, specifically thrombin and factor Xa, preventing excessive clotting and maintaining blood flow.
The global Antithrombin market was valued at US$ 512.7 million in 2023 and is anticipated to reach US$ 691.6 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
Antithrombin acts by binding to these clotting factors and forming a complex, which inactivates them and prevents their ability to promote the conversion of fibrinogen into fibrin, the insoluble protein that forms blood clots. By inhibiting thrombin and factor Xa, antithrombin interrupts the clotting cascade and helps to prevent the formation of unwanted blood clots.Antithrombin is also used as a pharmacological agent in certain medical conditions, such as during surgery or in high-risk thrombotic situations, to prevent blood clot formation. It can be administered intravenously as a medication to help maintain normal blood clotting function.
This report aims to provide a comprehensive presentation of the global market for Antithrombin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antithrombin.
Report Scope
The Antithrombin market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antithrombin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antithrombin companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Grifols
rEVO Biologics Inc.
Takeda
Kedrion S.p.A.
CSL Limited
Scripps Laboratories Inc.
Lee Biosolutions
Segment by Type
Liquid
Lyophilized
Segment by Application
Diagnostics
Therapeutics
Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antithrombin companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Antithrombin is a protein in the blood that plays a crucial role in regulating blood clotting. It is a natural anticoagulant that inhibits or blocks the activity of certain clotting factors, specifically thrombin and factor Xa, preventing excessive clotting and maintaining blood flow.
The global Antithrombin market was valued at US$ 512.7 million in 2023 and is anticipated to reach US$ 691.6 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
Antithrombin acts by binding to these clotting factors and forming a complex, which inactivates them and prevents their ability to promote the conversion of fibrinogen into fibrin, the insoluble protein that forms blood clots. By inhibiting thrombin and factor Xa, antithrombin interrupts the clotting cascade and helps to prevent the formation of unwanted blood clots.Antithrombin is also used as a pharmacological agent in certain medical conditions, such as during surgery or in high-risk thrombotic situations, to prevent blood clot formation. It can be administered intravenously as a medication to help maintain normal blood clotting function.
This report aims to provide a comprehensive presentation of the global market for Antithrombin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antithrombin.
Report Scope
The Antithrombin market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antithrombin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antithrombin companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Grifols
rEVO Biologics Inc.
Takeda
Kedrion S.p.A.
CSL Limited
Scripps Laboratories Inc.
Lee Biosolutions
Segment by Type
Liquid
Lyophilized
Segment by Application
Diagnostics
Therapeutics
Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antithrombin companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antithrombin Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Liquid
1.2.3 Lyophilized
1.3 Market by Application
1.3.1 Global Antithrombin Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Diagnostics
1.3.3 Therapeutics
1.3.4 Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antithrombin Market Perspective (2019-2030)
2.2 Antithrombin Growth Trends by Region
2.2.1 Global Antithrombin Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Antithrombin Historic Market Size by Region (2019-2024)
2.2.3 Antithrombin Forecasted Market Size by Region (2025-2030)
2.3 Antithrombin Market Dynamics
2.3.1 Antithrombin Industry Trends
2.3.2 Antithrombin Market Drivers
2.3.3 Antithrombin Market Challenges
2.3.4 Antithrombin Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antithrombin Players by Revenue
3.1.1 Global Top Antithrombin Players by Revenue (2019-2024)
3.1.2 Global Antithrombin Revenue Market Share by Players (2019-2024)
3.2 Global Antithrombin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antithrombin Revenue
3.4 Global Antithrombin Market Concentration Ratio
3.4.1 Global Antithrombin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antithrombin Revenue in 2023
3.5 Antithrombin Key Players Head office and Area Served
3.6 Key Players Antithrombin Product Solution and Service
3.7 Date of Enter into Antithrombin Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antithrombin Breakdown Data by Type
4.1 Global Antithrombin Historic Market Size by Type (2019-2024)
4.2 Global Antithrombin Forecasted Market Size by Type (2025-2030)
5 Antithrombin Breakdown Data by Application
5.1 Global Antithrombin Historic Market Size by Application (2019-2024)
5.2 Global Antithrombin Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Antithrombin Market Size (2019-2030)
6.2 North America Antithrombin Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Antithrombin Market Size by Country (2019-2024)
6.4 North America Antithrombin Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antithrombin Market Size (2019-2030)
7.2 Europe Antithrombin Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Antithrombin Market Size by Country (2019-2024)
7.4 Europe Antithrombin Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antithrombin Market Size (2019-2030)
8.2 Asia-Pacific Antithrombin Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Antithrombin Market Size by Region (2019-2024)
8.4 Asia-Pacific Antithrombin Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antithrombin Market Size (2019-2030)
9.2 Latin America Antithrombin Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Antithrombin Market Size by Country (2019-2024)
9.4 Latin America Antithrombin Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antithrombin Market Size (2019-2030)
10.2 Middle East & Africa Antithrombin Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Antithrombin Market Size by Country (2019-2024)
10.4 Middle East & Africa Antithrombin Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Grifols
11.1.1 Grifols Company Detail
11.1.2 Grifols Business Overview
11.1.3 Grifols Antithrombin Introduction
11.1.4 Grifols Revenue in Antithrombin Business (2019-2024)
11.1.5 Grifols Recent Development
11.2 rEVO Biologics Inc.
11.2.1 rEVO Biologics Inc. Company Detail
11.2.2 rEVO Biologics Inc. Business Overview
11.2.3 rEVO Biologics Inc. Antithrombin Introduction
11.2.4 rEVO Biologics Inc. Revenue in Antithrombin Business (2019-2024)
11.2.5 rEVO Biologics Inc. Recent Development
11.3 Takeda
11.3.1 Takeda Company Detail
11.3.2 Takeda Business Overview
11.3.3 Takeda Antithrombin Introduction
11.3.4 Takeda Revenue in Antithrombin Business (2019-2024)
11.3.5 Takeda Recent Development
11.4 Kedrion S.p.A.
11.4.1 Kedrion S.p.A. Company Detail
11.4.2 Kedrion S.p.A. Business Overview
11.4.3 Kedrion S.p.A. Antithrombin Introduction
11.4.4 Kedrion S.p.A. Revenue in Antithrombin Business (2019-2024)
11.4.5 Kedrion S.p.A. Recent Development
11.5 CSL Limited
11.5.1 CSL Limited Company Detail
11.5.2 CSL Limited Business Overview
11.5.3 CSL Limited Antithrombin Introduction
11.5.4 CSL Limited Revenue in Antithrombin Business (2019-2024)
11.5.5 CSL Limited Recent Development
11.6 Scripps Laboratories Inc.
11.6.1 Scripps Laboratories Inc. Company Detail
11.6.2 Scripps Laboratories Inc. Business Overview
11.6.3 Scripps Laboratories Inc. Antithrombin Introduction
11.6.4 Scripps Laboratories Inc. Revenue in Antithrombin Business (2019-2024)
11.6.5 Scripps Laboratories Inc. Recent Development
11.7 Lee Biosolutions
11.7.1 Lee Biosolutions Company Detail
11.7.2 Lee Biosolutions Business Overview
11.7.3 Lee Biosolutions Antithrombin Introduction
11.7.4 Lee Biosolutions Revenue in Antithrombin Business (2019-2024)
11.7.5 Lee Biosolutions Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Antithrombin Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Liquid
Table 3. Key Players of Lyophilized
Table 4. Global Antithrombin Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Antithrombin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Antithrombin Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Antithrombin Market Share by Region (2019-2024)
Table 8. Global Antithrombin Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Antithrombin Market Share by Region (2025-2030)
Table 10. Antithrombin Market Trends
Table 11. Antithrombin Market Drivers
Table 12. Antithrombin Market Challenges
Table 13. Antithrombin Market Restraints
Table 14. Global Antithrombin Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Antithrombin Market Share by Players (2019-2024)
Table 16. Global Top Antithrombin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antithrombin as of 2023)
Table 17. Ranking of Global Top Antithrombin Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Antithrombin Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Antithrombin Product Solution and Service
Table 21. Date of Enter into Antithrombin Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Antithrombin Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Antithrombin Revenue Market Share by Type (2019-2024)
Table 25. Global Antithrombin Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Antithrombin Revenue Market Share by Type (2025-2030)
Table 27. Global Antithrombin Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Antithrombin Revenue Market Share by Application (2019-2024)
Table 29. Global Antithrombin Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Antithrombin Revenue Market Share by Application (2025-2030)
Table 31. North America Antithrombin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Antithrombin Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Antithrombin Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Antithrombin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Antithrombin Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Antithrombin Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Antithrombin Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Antithrombin Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Antithrombin Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Antithrombin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Antithrombin Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Antithrombin Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Antithrombin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Antithrombin Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Antithrombin Market Size by Country (2025-2030) & (US$ Million)
Table 46. Grifols Company Detail
Table 47. Grifols Business Overview
Table 48. Grifols Antithrombin Product
Table 49. Grifols Revenue in Antithrombin Business (2019-2024) & (US$ Million)
Table 50. Grifols Recent Development
Table 51. rEVO Biologics Inc. Company Detail
Table 52. rEVO Biologics Inc. Business Overview
Table 53. rEVO Biologics Inc. Antithrombin Product
Table 54. rEVO Biologics Inc. Revenue in Antithrombin Business (2019-2024) & (US$ Million)
Table 55. rEVO Biologics Inc. Recent Development
Table 56. Takeda Company Detail
Table 57. Takeda Business Overview
Table 58. Takeda Antithrombin Product
Table 59. Takeda Revenue in Antithrombin Business (2019-2024) & (US$ Million)
Table 60. Takeda Recent Development
Table 61. Kedrion S.p.A. Company Detail
Table 62. Kedrion S.p.A. Business Overview
Table 63. Kedrion S.p.A. Antithrombin Product
Table 64. Kedrion S.p.A. Revenue in Antithrombin Business (2019-2024) & (US$ Million)
Table 65. Kedrion S.p.A. Recent Development
Table 66. CSL Limited Company Detail
Table 67. CSL Limited Business Overview
Table 68. CSL Limited Antithrombin Product
Table 69. CSL Limited Revenue in Antithrombin Business (2019-2024) & (US$ Million)
Table 70. CSL Limited Recent Development
Table 71. Scripps Laboratories Inc. Company Detail
Table 72. Scripps Laboratories Inc. Business Overview
Table 73. Scripps Laboratories Inc. Antithrombin Product
Table 74. Scripps Laboratories Inc. Revenue in Antithrombin Business (2019-2024) & (US$ Million)
Table 75. Scripps Laboratories Inc. Recent Development
Table 76. Lee Biosolutions Company Detail
Table 77. Lee Biosolutions Business Overview
Table 78. Lee Biosolutions Antithrombin Product
Table 79. Lee Biosolutions Revenue in Antithrombin Business (2019-2024) & (US$ Million)
Table 80. Lee Biosolutions Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antithrombin Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Antithrombin Market Share by Type: 2023 VS 2030
Figure 3. Liquid Features
Figure 4. Lyophilized Features
Figure 5. Global Antithrombin Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Antithrombin Market Share by Application: 2023 VS 2030
Figure 7. Diagnostics Case Studies
Figure 8. Therapeutics Case Studies
Figure 9. Research Case Studies
Figure 10. Antithrombin Report Years Considered
Figure 11. Global Antithrombin Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Antithrombin Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Antithrombin Market Share by Region: 2023 VS 2030
Figure 14. Global Antithrombin Market Share by Players in 2023
Figure 15. Global Top Antithrombin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antithrombin as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Antithrombin Revenue in 2023
Figure 17. North America Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Antithrombin Market Share by Country (2019-2030)
Figure 19. United States Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Antithrombin Market Share by Country (2019-2030)
Figure 23. Germany Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Antithrombin Market Share by Region (2019-2030)
Figure 31. China Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Antithrombin Market Share by Country (2019-2030)
Figure 39. Mexico Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Antithrombin Market Share by Country (2019-2030)
Figure 43. Turkey Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Grifols Revenue Growth Rate in Antithrombin Business (2019-2024)
Figure 46. rEVO Biologics Inc. Revenue Growth Rate in Antithrombin Business (2019-2024)
Figure 47. Takeda Revenue Growth Rate in Antithrombin Business (2019-2024)
Figure 48. Kedrion S.p.A. Revenue Growth Rate in Antithrombin Business (2019-2024)
Figure 49. CSL Limited Revenue Growth Rate in Antithrombin Business (2019-2024)
Figure 50. Scripps Laboratories Inc. Revenue Growth Rate in Antithrombin Business (2019-2024)
Figure 51. Lee Biosolutions Revenue Growth Rate in Antithrombin Business (2019-2024)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
